SOX1 and nasopharyngeal carcinoma: To determine whether promoter methylation was involved in regulating SOX1, two NPC cell lines (CNE2 and HONE1) were treated with 5-AZA-2′-deoxycytidine (5-Aza-CdR), a DNA methyltransferase inhibitor.